T0	Participants 66 95	after GnRH agonist treatment.
T1	Participants 169 196	hormone replacement therapy
T2	Participants 291 344	28 patients treated for 6 months with a GnRH agonist.
T3	Participants 391 453	postmenopausal women with high bone turnover treated with HRT.
T4	Participants 1609 1639	women with ovarian deficiency.